These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 26846019)

  • 21. [Antiviral treatment reduces risk of hepatocellular carcinoma in patients with hepatitis C virus-related chronic hepatitis and cirrhosis].
    Kasahara A; Hiramatsu N
    Nihon Rinsho; 2011 May; 69 Suppl 4():314-8. PubMed ID: 22096937
    [No Abstract]   [Full Text] [Related]  

  • 22. [HCV infection among cirrhotic patients as a risk factor for generation of hepatocellular carcinoma: preliminary report].
    Kobayashi S; Nagai Y; Nakao T; Nogami H; Isono K
    Nihon Geka Gakkai Zasshi; 1991 Nov; 92(11):1666. PubMed ID: 1722866
    [No Abstract]   [Full Text] [Related]  

  • 23. [Histological findings in the liver in patients with chronic hepatitis C].
    Takase K; Shiraki K
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):434-8. PubMed ID: 15359838
    [No Abstract]   [Full Text] [Related]  

  • 24. [Does interferon therapy on type C liver cirrhosis prevent the occurrence of hepatocellular carcinoma?].
    Harada H; Iga D; Arisaka Y; Mitsuhashi Y; Kamitsukasa H; Yagura M; Endou H; Kawashima H
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):754-8. PubMed ID: 7563870
    [No Abstract]   [Full Text] [Related]  

  • 25. Risk factors for hepatocellular carcinoma in HCV-cirrhosis: what we know and what is missing.
    Fattovich G; Llovet JM
    J Hepatol; 2006 Jun; 44(6):1013-6. PubMed ID: 16678654
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical aspects of type-C cirrhosis of liver--diagnosis, clinical course, treatment and prognosis].
    Yamada G
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):590-5. PubMed ID: 15359866
    [No Abstract]   [Full Text] [Related]  

  • 27. Hepatocellular carcinoma and viral cirrhosis.
    Gentilini P; Melani L; Riccardi D; Casini Raggi V; Romanelli RG
    Hepatology; 1994 Sep; 20(3):764-5. PubMed ID: 8076933
    [No Abstract]   [Full Text] [Related]  

  • 28. [Interferon-treated hepatitis C virus(HCV) patients with sustained biochemical response without eradication of HCV(asymptomatic HCV carrier)].
    Nakamura I; Imawari M
    Nihon Rinsho; 2001 Jul; 59(7):1284-8. PubMed ID: 11494538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.
    Fattovich G; Pantalena M; Zagni I; Realdi G; Schalm SW; Christensen E;
    Am J Gastroenterol; 2002 Nov; 97(11):2886-95. PubMed ID: 12425564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence and risk factors of hepatocellular carcinoma in patients with primary biliary cirrhosis.
    Macaron C; Hanouneh IA; Zein NN
    Hepatology; 2010 Dec; 52(6):2239; author reply 2239-40. PubMed ID: 21105115
    [No Abstract]   [Full Text] [Related]  

  • 31. [Steatosis and hepatitis C].
    Testino G
    Recenti Prog Med; 2005 Dec; 96(12):621-33; quiz 654. PubMed ID: 16496750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Surgical treatment for small hepatocellular carcinoma].
    Eguchi S; Furui J; Yanaga K; Kanematsu T
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():511-5. PubMed ID: 11762003
    [No Abstract]   [Full Text] [Related]  

  • 33. [Hepatitis C: from pathogenesis to treatment].
    Delarive J; Berger JP
    Schweiz Rundsch Med Prax; 1993 Nov; 82(45):1278-83. PubMed ID: 7505477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical study on relationship between hepatocellular carcinoma and hepatitis C virus infection in patients with chronic liver disease].
    Sata M; Tokeshi S; Nakano H; Majima Y; Tanikawa K
    Rinsho Byori; 1992 Sep; 40(9):929-34. PubMed ID: 1279247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of adjuvant interferon therapy on hepatitis b/c virus-related hepatocellular carcinoma after curative therapy - meta-analysis.
    Xu J; Li J; Chen J; Liu ZJ
    Adv Clin Exp Med; 2015; 24(2):331-40. PubMed ID: 25931368
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis C and interferon: fewer cases of liver cancer.
    Prescrire Int; 2013 Jul; 22(140):191. PubMed ID: 23951600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [High risk group for development of hepatocellular carcinoma].
    Koike Y; Shiratori Y
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():362-6. PubMed ID: 11761973
    [No Abstract]   [Full Text] [Related]  

  • 38. Liver cell dysplasia and hepatocellular carcinoma in non-A, non-B hepatitis.
    Lefkowitch JH; Apfelbaum TF
    Arch Pathol Lab Med; 1987 Feb; 111(2):170-3. PubMed ID: 3028314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Influence of heavy drinking for the development of hepatocellular carcinoma in type C cirrhosis].
    Chiba T; Tanaka N
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):731-5. PubMed ID: 7563865
    [No Abstract]   [Full Text] [Related]  

  • 40. [Optimal antiviral therapy of chronic hepatitis caused by hepatitis C virus].
    Cooreman MP; Stadhouders P
    Orv Hetil; 1997 Jun; 138(22 Suppl 1):1476-82. PubMed ID: 9221377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.